With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...

This story was originally reported by Barbara Rodriguez of The 19th. President Donald Trump and his administration are ...

The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization Program for all children. Subscribe to our newsletter for the latest sci-tech ...

Pneumococcal disease poses a severe risk to Indian adults, particularly those with chronic health issues. Despite effective ...

Merck & Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 STRIDE-13 trial evaluating CAPVAXIVE® (Pneumococcal 21-valent Conjugate ...

While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...

Measles is the most deadly of all childhood rash illnesses, according to the Florida Department of Health. Two children and an adult died this year in a measles outbreak in Texas.

Electronic medical records of 42 children with SCD diagnosed between 2009 and 2023 were retrospectively reviewed. Clinical demographic data and pneumococcal serologies were analysed. Of the 42 ...

Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...